Raymond James Financial Services Advisors’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-14,630
| Closed | -$9K | – | 2876 |
|
|
2018
Q4 | $9K | Sell |
14,630
-3,308
| -18% | -$2.04K | ﹤0.01% | 2531 |
|
|
2018
Q3 | $23K | Sell |
17,938
-1,518
| -8% | -$1.95K | ﹤0.01% | 2741 |
|
|
2018
Q2 | $26K | Buy |
19,456
+2,417
| +14% | +$3.23K | ﹤0.01% | 2695 |
|
|
2018
Q1 | $25K | Buy |
17,039
+5,091
| +43% | +$7.47K | ﹤0.01% | 2469 |
|
|
2017
Q4 | $27K | Buy |
11,948
+1,274
| +12% | +$2.88K | ﹤0.01% | 2450 |
|
|
2017
Q3 | $36K | Buy |
+10,674
| New | +$36K | ﹤0.01% | 2457 |
|